Zacks Investment Research on MSN3d
Sage Therapeutics (SAGE) Up 7.4% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Sage Therapeutics, Inc. (SAGE). Shares have added about 7.4% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
Local biotech company rebrands as Longevity Health Holdings
South Side-based biotech firm Carmell Corp. announced a comprehensive corporate rebrand and will now operate under the new ...
Longtime Bay Area biotech CEO abruptly steps down
John "Chip" Scarlett, who as chairman, president and CEO repositioned Geron Corp. and guided the company to its first drug ...
Sage moved to Underperform at BofA; says Biogen’s buyout impact has passed
Sage Therapeutics (NASDAQ:SAGE) stock drops as Bank of America issues an Underperform rating citing an end to Biogen's (BIIB) ...